This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
Top Stock Reports for Berkshire Hathaway, Roche & RTX
by Mark Vickery
Berkshire Hathaway, Roche and RTX headline today's research, with earnings drivers, growth catalysts and risks shaping their outlooks.
RHHBYPositive Net Change PSANegative Net Change BRK.BNo Net Change LITEPositive Net Change EMLPositive Net Change ASRVPositive Net Change RTXPositive Net Change RKLBNegative Net Change
aerospace finance industrial-products insurance pharmaceuticals
5 Life Insurance Stocks to Watch Despite Low-Interest Rate Environment
by Tanuka De
Redesigning and repricing of products and services amid a low-rate environment are likely to help Zacks Life Insurance industry players like AVVIY, RGA, PRI, VOYA and LNC. These companies are investing heavily in digitization.
LNCPositive Net Change RGANegative Net Change PRINegative Net Change VOYAPositive Net Change AVVIYPositive Net Change
insurance
THG Stock Trades at 2.16x Book Value: Is the Valuation Worth It?
by Zacks Equity Research
The Hanover's pricing discipline, strong Specialty margins and higher investment income support earnings, while AI boosts efficiency.
THGNegative Net Change AFGNegative Net Change ACGLNegative Net Change MCYNegative Net Change
finance insurance
ACGL's Insurance Segment Faces Competitive and Margin Pressures
by Zacks Equity Research
Arch Capital faces pressure from softer property pricing and catastrophe losses, weighing on Insurance segment growth and underwriting margins.
ACGLNegative Net Change WRBNegative Net Change CINFPositive Net Change
finance insurance
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
by Rajshree Sipani
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
UNHNegative Net Change ELVNegative Net Change
artificial-intelligence automation dividend-yield earnings-outlook earnings-surprise healthcare hmo hospitals insurance oncology-screening smart-health
Aegon Adds EUR 150 Million to Buybacks: What's Powering the Move?
by Zacks Equity Research
AEG expands its 2026 buyback by EUR 150 million as strong profits, capital generation and cash flow support returns.
AEGPositive Net Change CNONegative Net Change AIZNegative Net Change HMNNegative Net Change
finance insurance
3 Insurers to Focus on as Insurance Pricing Momentum Moderates
by Sushmita Sarker
As U.S. insurance pricing moderates, insurers like TRV, CB, and WRB are turning to new business, retention, exposure growth and market share to sustain growth.
TRVNegative Net Change CBNegative Net Change WRBNegative Net Change
insurance
CNA Lags Industry, Trades at a Discount: Time to Hold or Buy?
by Zacks Equity Research
CNA Financial's premium growth, strong investment income and disciplined underwriting support earnings, while casualty claims and softer pricing pose risks.
CNANegative Net Change RNRNegative Net Change FAFPositive Net Change NMIHNegative Net Change
finance insurance
Globe Life's Health Insurance Growth Powers Earnings Momentum
by Zacks Equity Research
GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.
GLNegative Net Change CNONegative Net Change AFLNegative Net Change
finance insurance
AJG's Organic Growth Resilience Supports Long-Term Expansion
by Sushmita Sarker
Arthur J. Gallagher's durable organic growth, margin expansion and AssuredPartners integration support its outlook as insurance pricing moderates.
AJGNegative Net Change BRONegative Net Change WTWNegative Net Change
insurance